Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

Bullboard Posts

Comment by Nohandledzepon Apr 23, 2014 8:24pm

188 Views

Post# 22484251

RE:RE:RE:Warren_Buffet / Grammagout

I'd rather see them ease off on the " oh there is still much uncertainty" theme and admit that this trial, as both analysts have, is on a straight track to FDA approval... With the only obstacle being time.

Of course that would lead to a higher shre price and minimal dilution. Why tell your story and dilute at$1.50 when you can dilute your shareholders into oblivion at 30 cents?

I am watching for 50 mil shares at 30 cents, with the FDA conveniently approving the requested patient selection process immediately after. According to Wedbush that is the real catalyst...

Bullboard Posts

Options trading in a volatile macro environment